OptiBiotix Health Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	0.87	0.64	0.46	2.21	1.52	Upgrade
Revenue Growth (YoY)	35.09%	40.92%	-79.35%	45.28%	121.54%	Upgrade
Cost of Revenue	0.54	0.32	0.21	1.09	0.64	Upgrade
Gross Profit	0.33	0.32	0.24	1.12	0.88	Upgrade
Selling, General & Admin	2.3	1.79	2.51	2.2	1.74	Upgrade
Research & Development	0.29	0.22	-	-	-	Upgrade
Operating Expenses	2.6	2.02	2.73	2.49	1.99	Upgrade
Operating Income	-2.27	-1.7	-2.49	-1.37	-1.11	Upgrade
Interest Expense	-	-	-	-0.05	-0.04	Upgrade
Interest & Investment Income	0	0	-	-	0	Upgrade
Earnings From Equity Investments	-0.35	-0.32	-0.08	-	-0.3	Upgrade
EBT Excluding Unusual Items	-2.62	-2.02	-2.57	-1.41	-1.46	Upgrade
Gain (Loss) on Sale of Investments	0.75	-0.03	-16.63	7.59	7.17	Upgrade
Gain (Loss) on Sale of Assets	-	-	21.65	-	-	Upgrade
Pretax Income	-1.87	-2.04	2.44	6.18	5.71	Upgrade
Income Tax Expense	-0.06	-0	-0.15	-0.08	-0.09	Upgrade
Earnings From Continuing Operations	-1.81	-2.04	2.59	6.26	5.8	Upgrade
Net Income	-1.81	-2.04	2.59	6.26	5.8	Upgrade
Net Income to Common	-1.81	-2.04	2.59	6.26	5.8	Upgrade
Net Income Growth	-	-	-58.68%	7.91%	-	Upgrade
Shares Outstanding (Basic)	98	90	88	88	87	Upgrade
Shares Outstanding (Diluted)	98	90	93	96	96	Upgrade
Shares Change (YoY)	8.55%	-3.24%	-2.43%	-0.03%	12.09%	Upgrade
EPS (Basic)	-0.02	-0.02	0.03	0.07	0.07	Upgrade
EPS (Diluted)	-0.02	-0.02	0.03	0.07	0.06	Upgrade
EPS Growth	-	-	-57.56%	7.91%	-	Upgrade
Free Cash Flow	-1.77	-1.53	-1.11	-1.57	-0.93	Upgrade
Free Cash Flow Per Share	-0.02	-0.02	-0.01	-0.02	-0.01	Upgrade
Gross Margin	38.05%	49.69%	53.39%	50.75%	57.76%	Upgrade
Operating Margin	-260.46%	-263.35%	-544.64%	-61.68%	-72.96%	Upgrade
Profit Margin	-207.47%	-316.62%	566.08%	282.92%	380.89%	Upgrade
Free Cash Flow Margin	-203.22%	-237.11%	-242.67%	-70.72%	-60.92%	Upgrade
EBITDA	-2.06	-1.49	-2.27	-1.08	-0.86	Upgrade
EBITDA Margin	-236.44%	-231.52%	-	-48.67%	-56.69%	Upgrade
D&A For EBITDA	0.21	0.21	0.22	0.29	0.25	Upgrade
EBIT	-2.27	-1.7	-2.49	-1.37	-1.11	Upgrade
EBIT Margin	-260.46%	-263.35%	-	-61.68%	-72.96%	Upgrade

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.